Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing.
A team of Chinese scientists has used targeted gene editing to develop rice that produces coenzyme Q10 (CoQ10), a vital ...
Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...
Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...
No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...
Onlymyhealth on MSN1d
Sickle Cell Disease Surges In Rajasthan’s Tribal Districts, Over 10,000 Affected: ReportThe spread of Sickle Cell Disease (SCD) has reached concerning levels in Rajasthan, particularly in its tribal districts.
The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the ...
A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.
Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public ...
For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...
"People who suffer from sickle cell have challenges that I don't believe we all know," Philpart said. "Sometimes it gets lost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback